Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) vectors are effective gene delivery vehicles mediating long-lasting transgene expression. Data from a clinical trial of AAV2-mediated hepatic transfer of the Factor IX gene (F9) into hemophilia B subjects suggests that CTL responses against AAV capsid can eliminate transduced hepatocytes and prevent long-term F9 expression. However, the capacity of hepatocytes to present AAV capsid-derived antigens has not been formally demonstrated, nor whether transduction by AAV sensitizes hepatocytes for CTL-mediated destruction. To investigate the fate of capsids after transduction, we engineered a soluble TCR for the detection of capsid-derived peptide:MHC I (pMHC) complexes. TCR multimers exhibited antigen and HLA specificity and possessed high binding affinity for cognate pMHC complexes. With this reagent, capsid pMHC complexes were detectable by confocal microscopy following AAV-mediated transduction of human hepatocytes. Although antigen presentation was modest, it was sufficient to flag transduced cells for CTL-mediated lysis in an in vitro killing assay. Destruction of hepatocytes was inhibited by soluble TCR, demonstrating a possible application for this reagent in blocking undesirable CTL responses. Together, these studies provide a mechanism for the loss of transgene expression and transient elevations in aminotransferases following AAV-mediated hepatic gene transfer in humans and a potential therapeutic intervention to abrogate these limitations imposed by the host T cell response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional characterization showed capsid-specific CD8+ T cells eliminate human hepatocytes after cross-presentation of capsid peptides on MHC I in vitro [89].”
From Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer (2023) · cites this paper as [89]
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“Soluble MHC multimers were developed over a decade ago and have been used successfully to enumerate antigen-specific T cells (11).”
MethodCytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164 · cited 1×
“In a phase I clinical trial the superagonist anti-CD28 monoclonal antibody TGN1412 induced a massive cytokine storm in human recipients, resulting in multiorgan failure in 6 healthy volunteers at 1/500th the dose that appeared safe in mice and nonhuman primates (44).”
BackgroundManno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163 · cited 7×
“The studies above support previous observations from a human clinical trial of AAV-mediated hepatic gene transfer in which transgene expression was transient and coincided with selflimited elevations in circulating markers of hepatocyte injury (1).”
BackgroundResultInfluentialSelf-citationLIGAND RECOGNITION BY αβ T CELL RECEPTORS
Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B., & Chien, Y.-H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.523 · Cited by 924
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758 · cited 1×
“In this regard, both liver sinusoidal endothelial cells (36) and hepatocytes (37) have been shown to be capable of presenting exogenous antigen, although the molecular details have yet to be completely elucidated.”
BackgroundER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., van Endert, P., & Amigorena, S. (2003) · Nature · doi:10.1038/nature01911 · Cited by 753 · cited 1×
“If a preformed capsid engages antigen processing machinery while still within endosomes, then cross-presentation pathways are likely involved (34, 35).”
BackgroundCd8(+) T-Cell Responses to Adeno-Associated Virus Capsid in Humans
Mingozzi, F., Maus, M. V., Hui, D. J., Sabatino, D. E., Murphy, S. L., Rasko, J. E. J., Ragni, M. V., Manno, C. S., Sommer, J., Jiang, H., et al. (2007) · Nature Medicine · doi:10.1038/nm1549 · Cited by 748 · cited 5×
“In addition, AAV2 capsid–specific CD8+ T cells were detectable following vector administration, and their frequency expanded and contracted in temporal correlation with hepatocellular injury (2).”
BackgroundMethodInfluentialSelf-citationEvidence that a Single Peptide–MHC Complex on a Target Cell Can Elicit a Cytolytic T Cell Response
Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J., & Eisen, H. N. (1996) · Immunity · doi:10.1016/s1074-7613(00)80483-5 · Cited by 703
Phagosomes are competent organelles for antigen cross-presentation
Houde, M., Bertholet, S., Gagnon, E., Brunet, S., Goyette, G., Laplante, A., Princiotta, M. F., Thibault, P., Sacks, D., & Desjardins, M. (2003) · Nature · doi:10.1038/nature01912 · Cited by 699 · cited 1×
“If a preformed capsid engages antigen processing machinery while still within endosomes, then cross-presentation pathways are likely involved (34, 35).”
BackgroundT cell killing does not require the formation of a stable mature immunological synapse
Purbhoo, M. A., Irvine, D. J., Huppa, J. B., & Davis, M. M. (2004) · Nature Immunology · doi:10.1038/ni1058 · Cited by 577 · cited 1×
“In an alternative approach, CTLs have been shown to have detectable increases in intracellular calcium after stimulation by 1 pMHC complex, inducible cytotoxic activity by 1–3 complexes, and maximal calcium flux with mature immunologic synapse formation by 8–10 complexes (42, 43).”
BackgroundPhenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96.
Altman, J. D., Moss, P. A. H., Goulder, P., Barouch, D. H., McHeyzer‐Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (2011) · PubMed · Cited by 572
Induction of Immune Tolerance to Coagulation Factor IX Antigen by In Vivo Hepatic Gene Transfer
Mingozzi, F., Liu, Y.-L., Dobrzynski, E., Kaufhold, A., Liu, J. H., Wang, Y., Arruda, V. R., High, K. A., & Herzog, R. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16887 · Cited by 466
Self-citationSnyder, R. O., Miao, C., Meuse, L., Tubb, J., Donahue, B. A., Lin, H.-F., Stafford, D. W., Patel, S., Thompson, A. R., Nichols, T., et al. (1999) · Nature Medicine · doi:10.1038/4751 · Cited by 409
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
Duan, D., Yue, Y., Yan, Z., Yang, J., & Engelhardt, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8317 · Cited by 391 · cited 1×
“It has been demonstrated that ubiquitination of AAV capsid proteins occurs after endocytosis (28, 29) and is facilitated by EGFR-PTK signaling (30).”
BackgroundMount, J. D., Herzog, R. W., Tillson, D. M., Goodman, S. A., Robinson, N., McCleland, M. L., Bellinger, D., Nichols, T. C., Arruda, V. R., Lothrop, C. D., et al. (2002) · Blood · doi:10.1182/blood.v99.8.2670 · Cited by 339
Self-citationJiang, H., Couto, L. B., Patarroyo-White, S., Liu, T., Nagy, D., Vargas, J. A., Zhou, S., Scallan, C. D., Sommer, J., Vijay, S., et al. (2006) · Blood · doi:10.1182/blood-2006-04-017913 · Cited by 330 · cited 1×
“Immunosuppression protocols have been evaluated for inhibiting undesirable host immune responses during gene therapy (7, 8).”
BackgroundSelf-citationInterferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Nguyen, K. B., Cousens, L. P., Doughty, L. A., Pien, G. C., Durbin, J. E., & Biron, C. A. (2000) · Nature Immunology · doi:10.1038/76940 · Cited by 303
Self-citationDouar, A.-M., Poulard, K., Stockholm, D., & Danos, O. (2001) · Journal of Virology · doi:10.1128/jvi.75.4.1824-1833.2001 · Cited by 282
Craiu, A., Akopian, T., Goldberg, A., & Rock, K. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10850 · Cited by 264 · cited 1×
“Intact pre-formed proteins in the cytosol can access MHC I pathways, as cytosolic microinjection of ovalbumin protein results in subsequent antigen presentation on MHC I (38, 39).”
BackgroundMingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080093 · Cited by 254 · cited 1×
“Immunosuppression protocols have been evaluated for inhibiting undesirable host immune responses during gene therapy (7, 8).”
BackgroundSelf-citationYan, Z., Zak, R., Luxton, G. W. G., Ritchie, T. C., Bantel-Schaal, U., & Engelhardt, J. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2043-2053.2002 · Cited by 222 · cited 1×
“It has been demonstrated that ubiquitination of AAV capsid proteins occurs after endocytosis (28, 29) and is facilitated by EGFR-PTK signaling (30).”
BackgroundCao, O., Dobrzynski, E., Wang, L., Nayak, S., Mingle, B., Terhorst, C., & Herzog, R. W. (2007) · Blood · doi:10.1182/blood-2007-02-073304 · Cited by 220
Tsomides, T. J., Aldovini, A., Johnson, R. P., Walker, B. D., Young, R. A., & Eisen, H. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1283 · Cited by 211 · cited 1×
“Using cell lines that stably express HIV-1 to recover endogenously processed viral peptides, it has been demonstrated that target cells can be sensitized by as few as 10–100 peptides for lysis by HIV-specific CTLs (41).”
BackgroundPreclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy
Grimm, D., Zhou, S., Nakai, H., Thomas, C. E., Storm, T. A., Fuess, S., Matsushita, T., Allen, J., Surosky, R., Lochrie, M., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0495 · Cited by 208 · cited 1×
“subsequent CsCl density gradient purification (50).”
Self-citationLoss of Siglec expression on T lymphocytes during human evolution
Nguyen, D. H., Hurtado-Ziola, N., Gagneux, P., & Varki, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510484103 · Cited by 204 · cited 1×
“Human T cells also proliferate more vigorously after TCR activation than do T cells from chimpanzees, and this difference has been attributed to loss of inhibitory Siglec expression during human evolution (46).”
BackgroundLIGAND RECOGNITION BY T CELL RECEPTORS
Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D. S., Hampl, J., Arden, B., & Chien, Y. (1998) · Cited by 196
Wang, L., Nichols, T. C., Read, M. S., Bellinger, D. A., & Verma, I. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0031 · Cited by 176
Wang, L., Calcedo, R., Nichols, T. C., Bellinger, D. A., Dillow, A., Verma, I. M., & Wilson, J. M. (2005) · Blood · doi:10.1182/blood-2004-10-3867 · Cited by 173
Nathwani, A. C., Davidoff, A. M., Hanawa, H., Hu, Y., Hoffer, F. A., Nikanorov, A., Slaughter, C., Ng, C. Y. C., Zhou, J., Lozier, J. N., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0589 · Cited by 164
Qu, G., Bahr-Davidson, J., Prado, J., Tai, A., Cataniag, F., McDonnell, J., Zhou, J.-M., Hauck, B., Luna, J., Sommer, J. M., et al. (2006) · Journal of Virological Methods · doi:10.1016/j.jviromet.2006.11.019 · Cited by 163 · cited 1×
“This underscores the importance of minimizing contamination by empty capsids during the manufacturing process (40), to increase transduction efficiency while reducing capsid antigen burden.”
BackgroundSelf-citationArruda, V. R., Stedman, H. H., Nichols, T. C., Haskins, M. E., Nicholson, M., Herzog, R. W., Couto, L. B., & High, K. A. (2005) · Blood · doi:10.1182/blood-2004-07-2908 · Cited by 153
Self-citationZhong, L., Zhao, W., Wu, J., Li, B., Zolotukhin, S., Govindasamy, L., Agbandje-McKenna, M., & Srivastava, A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300170 · Cited by 146 · cited 1×
“It has been demonstrated that ubiquitination of AAV capsid proteins occurs after endocytosis (28, 29) and is facilitated by EGFR-PTK signaling (30).”
BackgroundWang, L., Figueredo, J., Calcedo, R., Lin, J., & Wilson, J. M. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.001 · Cited by 113 · cited 2×
“Based on animal studies, this has been considered an unlikely possibility by some investigators (4, 5).”
BackgroundPre-existing AAV Capsid-specific CD8+ T Cells are Unable to Eliminate AAV-transduced Hepatocytes
Li, H., Murphy, S. L., Giles-Davis, W., Edmonson, S., Xiang, Z., Li, Y., Lasaro, M. O., High, K. A., & Ertl, H. C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300090 · Cited by 108 · cited 1×
“Similarly, capsid-specific CD8+ T cells have been identified following administration of adenovirus expressing AAV2 capsid in mice (3, 6) or infusion of AAV vector in humans (2, 6).”
BackgroundSelf-citationIdentification of mouse AAV capsid-specific CD8+ T cell epitopes
Sabatino, D. E., Mingozzi, F., Hui, D. J., Chen, H., Colosi, P., Ertl, H. C. J., & High, K. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.009 · Cited by 91 · cited 2×
“Similarly, capsid-specific CD8+ T cells have been identified following administration of adenovirus expressing AAV2 capsid in mice (3, 6) or infusion of AAV vector in humans (2, 6).”
BackgroundSelf-citationHauck, B., Murphy, S. L., Smith, P. H., Qu, G., Liu, X., Zelenaia, O., Mingozzi, F., Sommer, J. M., High, K. A., & Wright, J. F. (2009) · Molecular Therapy · doi:10.1038/mt.2008.227 · Cited by 88 · cited 1×
“In particular, it remains unclear how AAV engages class I antigen presentation pathways in vivo, as capsid is not being expressed but rather is an exogenous antigen (27).”
BackgroundSelf-citationLi, C., Hirsch, M., Asokan, A., Zeithaml, B., Ma, H., Kafri, T., & Samulski, R. J. (2007) · Journal of Virology · doi:10.1128/jvi.00529-07 · Cited by 87 · cited 1×
“Based on animal studies, this has been considered an unlikely possibility by some investigators (4, 5).”
BackgroundBongfen, S. E., Torgler, R., Romero, J. F., Rénia, L., & Corradin, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7054 · Cited by 84
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
Waibler, Z., Sender, L. Y., Merten, C., Hartig, R., Kliche, S., Gunzer, M., Reichardt, P., Kalinke, U., & Schraven, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001708 · Cited by 79 · cited 1×
“Subsequent investigation demonstrated that superagonist activation of CD28 leads to a sustained calcium influx in human T cells, but not cynomolgus or rhesus monkey T cells (45).”
BackgroundLiver cell lines for the study of hepatocyte functions and immunological response
Clayton, R. F., Rinaldi, A., Kandyba, E. E., Edward, M., Willberg, C., Klenerman, P., & Patel, A. H. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01017.x · Cited by 79 · cited 14×
“In separate experiments, the human hepatocyte cell line HHL5 expressing HLA-A*0101 was cultured with (A) 10 μg/ml of SADNNNSEY capsid peptide, or the HLA-B*0702–expressing HHL5-B7 cell line was cultured with (B) 3 × 10 5 MOI AAV2-F9 vector or (C) 3 × 10 5 MOI AAV2-empty capsids devoid of genomes.”
BackgroundInfluentialDesign of Soluble Recombinant T Cell Receptors for Antigen Targeting and T Cell Inhibition
Laugel, B., Boulter, J. M., Lissin, N. M., Vuidepot, A., Li, Y., Emma Gostick, D., Alexander, L. E. C., Douek, D. C., Hemelaar, J., Price, D. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409427200 · Cited by 74 · cited 2×
“TCR multimers have previously been shown to inhibit CTL expansion (13) and secretion of MIP-1β (12) following antigenic stimulation.”
BackgroundDing, W., Yan, Z., Zak, R., Saavedra, M., Rodman, D. M., & Engelhardt, J. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7361-7366.2003 · Cited by 73
Type 1 IFNs and regulation of TH1 responses: enigmas both resolved and emerge
O’Shea, J. J., & Visconti, R. (2000) · Nature Immunology · doi:10.1038/76872 · Cited by 63 · cited 1×
“Differences between human and murine T cells also exist, as type I IFNs can drive T cell IFN-γ production from humans but not mice due to divergent regulation of STAT1 signaling pathways (47, 48).”
BackgroundHacker, U. T., Wingenfeld, L., Kofler, D. M., Schuhmann, N. K., Lutz, S., Herold, T., King, S. B. S., Gerner, F. M., Perabo, L., Rabinowitz, J., et al. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.782 · Cited by 63
Michalek, M. T., Grant, E. P., & Rock, K. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.617 · Cited by 52 · cited 1×
“Intact pre-formed proteins in the cytosol can access MHC I pathways, as cytosolic microinjection of ovalbumin protein results in subsequent antigen presentation on MHC I (38, 39).”
BackgroundChen, M., Tabaczewski, P., Truscott, S. M., Van Kaer, L., & Stroynowski, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1047 · Cited by 49
Senaldi, G., Lobo-Yeo, A., Mowat, A. P., Mieli‐Vergani, G., & Vergani, D. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.2.107 · Cited by 44
Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity
Subbramanian, R. A., Moriya, C., Martin, K. L., Peyerl, F. W., Hasegawa, A., Naoi, A., Chhay, H., Autissier, P., Gorgone, D. A., Lifton, M. A., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt1024 · Cited by 32 · cited 1×
“TCR multimers have previously been shown to inhibit CTL expansion (13) and secretion of MIP-1β (12) following antigenic stimulation.”
BackgroundZhu, X., Belmont, H. J., Price‐Schiavi, S. A., Bai, L., Lee, H.-I., Fernandez, M., Wong, R. L., Builes, J., Rhode, P. R., & Wong, H. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3223 · Cited by 28
Can oligomeric T-cell receptor be used as a tool to detect viral peptide epitopes on infected cells?
Anikeeva, N., Mareeva, T., Liu, W., & Sykulev, Y. K. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.025 · Cited by 13 · cited 1×
“Others have shown that flow cytometry can limit the detection of low-density pMHC complexes by soluble TCR, as compared with more sensitive confocal imaging (16).”
BackgroundChiu, J., Lui, W., Chang, H.-M., Loong, C., Wu, L., Kao, H.-L., & Wu, C.-W. (1997) · Cytometry · doi:10.1002/(sici)1097-0320(19971215)30:6<317::aid-cyto8>3.0.co;2-c · Cited by 10
Research works printed but not linked: 1
- Mingozzi, 2003, J. Clin. Invest., 111, 1347, 10.1172/JCI200316887 · doi:10.1172/jci200316887 · Paper page
Cited by
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Mingozzi, F., & High, K. A. (2013) · Blood · doi:10.1182/blood-2013-01-306647 · Cited by 955
“High vector doses may trigger anticapsid CTL responses 4,15,95,128 ; Relatively low-titer antibodies (1:5-1:17) can neutralize large doses of vector.”
InfluentialSelf-citationTherapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges
Mingozzi, F., & High, K. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2988 · Cited by 893
“By contrast, in vitro models of AAV antigen presentation and cytotoxic T lymphocyte-mediated clearance of transduced human cells have been more reliable tools for the study of AAV capsid antigen processing and presentatio”
MethodSelf-citationEmerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
“One important aspect of T cell-mediated immune responses to AAV is that they seem to be detected in a dose-dependent fashion, a result consistent with published in vitro antigen presentation data.(64,65) Above a certain threshold of capsid antigen load, activation of capsid-specific T cells may result in hepatotoxicit…”
BackgroundMethodResultSelf-citationAntigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2858 · Cited by 805
“; however, pre-existing AAV-specific memory T cells restricted long-term transgene expression in transduced hepatocyte”
Background
Metadata
- Authors
- Pien, G. C., Basner-Tschakarjan, E., Hui, D. J., Mentlik, A. N., Finn, J. D., Hasbrouck, N. C., Zhou, S., Murphy, S. L., Maus, M. V., Mingozzi, F., Orange, J. S., & High, K. A.
- Affiliations
- Children's Hospital of Philadelphia (US)
- Corresponding author
- High, Katherine A.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2009-06-01
- Volume
- 119
- Issue
- 6
- Pages
- 1688-1695
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2689109
- OpenAlex
- W2131862356
- Cited by
- 192
- References
- 51
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 13 · 2023: 10 · 2022: 13 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 10 · 2017: 15 · 2016: 8 · 2015: 13 · 2014: 13 · 2013: 13 · 2012: 11
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Children's Hospital of Philadelphia
- National Institutes of Health (AI067946)
- National Heart, Lung, and Blood Institute (P01HL078810, T32HL007439, T32HL007150)
- National Institute of Allergy and Infectious Diseases (R01 AI067946S1, R01AI067946)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007748)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus, antigen presentation, hepatocytes, cytotoxic T lymphocytes, T cell-mediated lysis, peptide-MHC class I complexes, AAV2, hemophilia B, hepatic gene transfer, aminotransferase elevation, host immune response
- MeSH terms
- Dependovirus, Cell Line, Cytotoxicity, Immunologic, Genetic Vectors, Histocompatibility Antigens, Humans, Receptors, Antigen, T-Cell, Solubility, Substrate Specificity, T-Lymphocytes, Cytotoxic, Antigen Presentation, Hepatocytes, Capsid Proteins, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.